Cash from Operations (TTM) Chart

View Cash from Operations (TTM) for UFPT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (TTM) Chart
Start Trial

Historical Cash from Operations (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 71.58M
March 31, 2026 81.30M
December 31, 2025 91.90M
September 30, 2025 99.49M
June 30, 2025 83.37M
March 31, 2025 69.75M
December 31, 2024 66.59M
September 30, 2024 54.87M
June 30, 2024 53.10M
March 31, 2024 50.26M
December 31, 2023 41.33M
September 30, 2023 46.52M
June 30, 2023 28.38M
March 31, 2023 22.68M
December 31, 2022 17.74M
September 30, 2022 0.474M
June 30, 2022 4.371M
March 31, 2022 7.743M
December 31, 2021 14.29M
September 30, 2021 21.97M
June 30, 2021 24.19M
March 31, 2021 23.63M
December 31, 2020 25.04M
September 30, 2020 25.58M
June 30, 2020 29.61M
Date Value
March 31, 2020 32.34M
December 31, 2019 31.23M
September 30, 2019 30.16M
June 30, 2019 26.23M
March 31, 2019 26.94M
December 31, 2018 21.32M
September 30, 2018 18.01M
June 30, 2018 16.99M
March 31, 2018 11.34M
December 31, 2017 17.47M
September 30, 2017 15.82M
June 30, 2017 15.74M
March 31, 2017 15.94M
December 31, 2016 9.393M
September 30, 2016 10.43M
June 30, 2016 8.989M
March 31, 2016 11.84M
December 31, 2015 13.10M
September 30, 2015 13.52M
June 30, 2015 14.87M
March 31, 2015 10.98M
December 31, 2014 11.13M
September 30, 2014 11.42M
June 30, 2014 12.97M
March 31, 2014 14.99M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
Abbott Laboratories 9.905B
AngioDynamics, Inc. 3.089M
Alphatec Holdings, Inc. 56.52M
AtriCure, Inc. 64.94M
Baxter International, Inc. 1.319B